A Randomized Pilot Study Evaluating Combination Dipeptidyl Peptidase-4 Inhibitor Sitagliptin Plus Metformin Compared to Metformin Monotherapy and Placebo on Metabolic Abnormalities in Women With a Recent History of GDM
Phase of Trial: Phase IV
Latest Information Update: 25 Jan 2018
At a glance
- Drugs Metformin/sitagliptin (Primary) ; Metformin
- Indications Gestational diabetes
- Focus Biomarker; Therapeutic Use
- 19 Jan 2018 Status changed from active, no longer recruiting to completed.
- 29 Aug 2017 Planned End Date changed from 1 Feb 2018 to 1 Oct 2017.
- 29 Aug 2017 Planned primary completion date changed from 1 Jan 2018 to 1 Sep 2017.